Inventor
TSUJI TAKEMASA
US14 patents
⚠️ This page may combine multiple inventors who share the name “TSUJI TAKEMASA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGENUS INC
9 patentsUS10280226B2May 7, 2019
Anti-GITR antibodies and methods of use thereof
AGENUS INC17 citations93
US10155818B2Dec 18, 2018
Anti-GITR antibodies and methods of use thereof
AGENUS INC17 citations93
US10836830B2Nov 17, 2020
Antibodies and methods of use thereof
AGENUS INC12 citations84
US10577426B2Mar 3, 2020
Anti-GITR antibodies and methods of use thereof
AGENUS INC3 citations82
US10829559B2Nov 10, 2020
Anti-GITR antibodies and methods of use thereof
AGENUS INC1 citations72
US11447557B2Sep 20, 2022
Antibodies and methods of use thereof
AGENUS INC3 citations71
US10800849B2Oct 13, 2020
Anti-GITR antibodies and methods of use thereof
AGENUS INC2 citations71
US11897962B2Feb 13, 2024
Anti-GITR antibodies and methods of use thereof
AGENUS INC0 citations62
US11401335B2Aug 2, 2022
Anti-GITR antibodies and methods of use thereof
AGENUS INC0 citations61
HEALTH RESEARCH INC
5 patentsUS10000546B2Jun 19, 2018
Compositions and method for use of recombinant T cell receptors for direct recognition of tumor antigen
HEALTH RESEARCH INC4 citations68
US12371470B2Jul 29, 2025
Compositions and methods for use of recombinant T cell receptors for direct recognition of tumor antigen
HEALTH RESEARCH INC0 citations57
US11155595B2Oct 26, 2021
Compositions and methods for use of recombinant T cell receptors for direct recognition of tumor antigen
HEALTH RESEARCH INC0 citations57
US12275946B2Apr 15, 2025
Compositions and methods for rapid cloning of t-cell receptors
HEALTH RESEARCH INC0 citations42
US11020431B2Jun 1, 2021
Compositions and libraries comprising recombinant T-cell receptors and methods of using recombinant T-cell receptors
HEALTH RESEARCH INC0 citations42